Skip to main navigation Skip to search Skip to main content

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: Pooled analysis of consecutive cohorts of the C-144-01 study

  • Jason Chesney
  • , Karl D. Lewis
  • , Harriet Kluger
  • , Omid Hamid
  • , Eric Whitman
  • , Sajeve Thomas
  • , Martin Wermke
  • , Mike Cusnir
  • , Evidio Domingo-Musibay
  • , Giao Q. Phan
  • , John M. Kirkwood
  • , Jessica C. Hassel
  • , Marlana Orloff
  • , James Larkin
  • , Jeffrey Weber
  • , Andrew J.S. Furness
  • , Nikhil I. Khushalani
  • , Theresa Medina
  • , Michael E. Egger
  • , Friedrich Graf Finckenstein
    • Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod Sarnaik

Research output: Contribution to journal › Article › peer-review

253   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: Pooled analysis of consecutive cohorts of the C-144-01 study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry